Aadi Bioscience, Inc. (AADI)
USD 2.05
(-2.38%)
USD 2.05
(-2.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -55.86 Million USD | -49.54% |
| 2022 | -37.35 Million USD | 74.82% |
| 2021 | -148.38 Million USD | -2657.9% |
| 2020 | 5.8 Million USD | 115.12% |
| 2019 | -38.35 Million USD | 38.74% |
| 2018 | -62.61 Million USD | -208.99% |
| 2017 | -20.26 Million USD | -288.03% |
| 2016 | 10.77 Million USD | 316.22% |
| 2015 | -4.98 Million USD | -2136.56% |
| 2014 | 244.73 Thousand USD | 14.51% |
| 2013 | 213.71 Thousand USD | 29.22% |
| 2012 | 165.39 Thousand USD | 42.73% |
| 2011 | 115.87 Thousand USD | 250.05% |
| 2010 | 33.1 Thousand USD | 138.87% |
| 2009 | 13.85 Thousand USD | 284.58% |
| 2008 | -7508.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -40.08 Million USD | 14.46% |
| 2024 Q1 | -46.86 Million USD | 16.12% |
| 2023 FY | -55.86 Million USD | -49.54% |
| 2023 Q2 | -66.69 Million USD | -105.35% |
| 2023 Q4 | -55.86 Million USD | 17.16% |
| 2023 Q1 | -32.47 Million USD | 13.06% |
| 2023 Q3 | -67.43 Million USD | -1.11% |
| 2022 Q2 | -116.96 Million USD | 9.51% |
| 2022 FY | -37.35 Million USD | 74.82% |
| 2022 Q4 | -37.35 Million USD | 71.93% |
| 2022 Q3 | -133.09 Million USD | -13.79% |
| 2022 Q1 | -129.26 Million USD | 12.89% |
| 2021 Q3 | -160.76 Million USD | -336.78% |
| 2021 Q2 | -36.8 Million USD | 5.55% |
| 2021 FY | -148.38 Million USD | -2657.9% |
| 2021 Q1 | -38.96 Million USD | -771.77% |
| 2021 Q4 | -148.38 Million USD | 7.7% |
| 2020 FY | 5.8 Million USD | 115.12% |
| 2020 Q2 | -44.74 Million USD | -377.77% |
| 2020 Q1 | 16.1 Million USD | 142.0% |
| 2020 Q3 | -47.18 Million USD | -5.46% |
| 2020 Q4 | 5.8 Million USD | 112.29% |
| 2019 Q1 | -52.89 Million USD | 15.52% |
| 2019 FY | -38.35 Million USD | 38.74% |
| 2019 Q3 | -42.95 Million USD | 9.9% |
| 2019 Q4 | -38.35 Million USD | 10.71% |
| 2019 Q2 | -47.67 Million USD | 9.87% |
| 2018 Q3 | -68.8 Million USD | -0.03% |
| 2018 Q4 | -62.61 Million USD | 9.0% |
| 2018 Q1 | -13.76 Million USD | 32.08% |
| 2018 FY | -62.61 Million USD | -208.99% |
| 2018 Q2 | -68.78 Million USD | -399.74% |
| 2017 FY | -20.26 Million USD | -288.03% |
| 2017 Q4 | -20.26 Million USD | 18.39% |
| 2017 Q1 | -35.13 Million USD | -21269.67% |
| 2017 Q2 | -28.84 Million USD | 17.9% |
| 2017 Q3 | -24.82 Million USD | 13.93% |
| 2016 Q2 | 149.72 Thousand USD | -51.19% |
| 2016 Q1 | 306.77 Thousand USD | 116.84% |
| 2016 Q4 | 165.98 Thousand USD | 2.36% |
| 2016 FY | 10.77 Million USD | 316.22% |
| 2016 Q3 | 162.16 Thousand USD | 8.31% |
| 2015 Q2 | 279.9 Thousand USD | 4.95% |
| 2015 Q4 | 141.47 Thousand USD | -50.14% |
| 2015 FY | -4.98 Million USD | -2136.56% |
| 2015 Q1 | 266.71 Thousand USD | 8.98% |
| 2015 Q3 | 283.73 Thousand USD | 1.37% |
| 2014 Q4 | 244.73 Thousand USD | 5.43% |
| 2014 FY | 244.73 Thousand USD | 14.51% |
| 2014 Q2 | 215.43 Thousand USD | 0.61% |
| 2014 Q3 | 232.13 Thousand USD | 7.75% |
| 2014 Q1 | 214.11 Thousand USD | 0.19% |
| 2013 Q2 | 201.58 Thousand USD | 20.49% |
| 2013 Q3 | 209.7 Thousand USD | 4.03% |
| 2013 Q4 | 213.71 Thousand USD | 1.91% |
| 2013 FY | 213.71 Thousand USD | 29.22% |
| 2013 Q1 | 167.29 Thousand USD | 1.15% |
| 2012 Q2 | 160.68 Thousand USD | 9.76% |
| 2012 FY | 165.39 Thousand USD | 42.73% |
| 2012 Q4 | 165.39 Thousand USD | 0.48% |
| 2012 Q3 | 164.6 Thousand USD | 2.44% |
| 2012 Q1 | 146.4 Thousand USD | 26.34% |
| 2011 FY | 115.87 Thousand USD | 250.05% |
| 2011 Q1 | 35.36 Thousand USD | 6.84% |
| 2011 Q2 | 110.77 Thousand USD | 213.21% |
| 2011 Q3 | 113.87 Thousand USD | 2.8% |
| 2011 Q4 | 115.87 Thousand USD | 1.76% |
| 2010 Q1 | 14 Thousand USD | 1.06% |
| 2010 Q3 | 32.74 Thousand USD | 11.99% |
| 2010 Q4 | 33.1 Thousand USD | 1.09% |
| 2010 Q2 | 29.24 Thousand USD | 108.78% |
| 2010 FY | 33.1 Thousand USD | 138.87% |
| 2009 Q4 | 13.85 Thousand USD | 15.78% |
| 2009 Q3 | 11.96 Thousand USD | 45.52% |
| 2009 Q2 | 8225.00 USD | 211.03% |
| 2009 Q1 | -7408.00 USD | 1.33% |
| 2009 FY | 13.85 Thousand USD | 284.58% |
| 2008 Q2 | -12.19 Thousand USD | 56.35% |
| 2008 Q3 | -9284.00 USD | 23.88% |
| 2008 FY | -7508.00 USD | 0.0% |
| 2008 Q4 | -7508.00 USD | 19.13% |
| 2008 Q1 | -27.93 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 61.25 Million USD | 191.196% |
| Jaguar Health, Inc. | 29.39 Million USD | 290.072% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 82.361% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -303.176% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 102.987% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -232.742% |
| ContextLogic Inc. | -232 Million USD | 75.921% |
| MiMedx Group, Inc. | -33.9 Million USD | -64.786% |
| MEI Pharma, Inc. | -3.7 Million USD | -1407.8% |
| AlloVir, Inc. | -62.69 Million USD | 10.891% |
| Novavax, Inc. | -298.29 Million USD | 81.272% |
| Aptorum Group Limited | 1.35 Million USD | 4216.589% |
| Ardelyx, Inc. | 34.51 Million USD | 261.868% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 1405.234% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 910.258% |
| Vaxcyte, Inc. | -368.22 Million USD | 84.829% |
| Precigen, Inc. | -481 Thousand USD | -11514.137% |
| Pharming Group N.V. | 109.8 Million USD | 150.876% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 76.95% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -221.131% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 301.0% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 68.12% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -2311.021% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -201.644% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -201.644% |
| Bicycle Therapeutics plc | -481.46 Million USD | 88.397% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -686.817% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -853.311% |
| Acelyrin, Inc. | -216.9 Million USD | 74.245% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -3140.371% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -721.167% |
| Senti Biosciences, Inc. | 1.74 Million USD | 3310.575% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 69.739% |
| AbCellera Biologics Inc. | -55.94 Million USD | 0.136% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -821.544% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 254.478% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 8995.541% |
| Chimerix, Inc. | -25.51 Million USD | -118.929% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 52.272% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 546.519% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 901.713% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 521.965% |
| Elevation Oncology, Inc. | -19.11 Million USD | -192.206% |
| Alkermes plc | -166.73 Million USD | 66.496% |
| Fortress Biotech, Inc. | 7.66 Million USD | 828.819% |
| Fortress Biotech, Inc. | 7.66 Million USD | 828.819% |
| Agenus Inc. | 274.13 Million USD | 120.378% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 49.461% |
| Dyadic International, Inc. | -6.37 Million USD | -775.872% |
| ImmuCell Corporation | 10.99 Million USD | 608.291% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -250.618% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 63.759% |
| Lantern Pharma Inc. | -21.7 Million USD | -157.399% |
| Immix Biopharma, Inc. | -17.5 Million USD | -219.044% |
| Incyte Corporation | -3.17 Billion USD | 98.241% |
| IO Biotech, Inc. | -140.69 Million USD | 60.295% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 1146.73% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -553.902% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 559.284% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 27.872% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -1037.991% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 56.733% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 423.324% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 150.387% |
| NextCure, Inc. | -6.47 Million USD | -762.498% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -10.62% |
| Onconetix, Inc. | 5.33 Million USD | 1147.823% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -775.749% |
| Opthea Limited | 28.15 Million USD | 298.399% |
| PDS Biotechnology Corporation | -32.7 Million USD | -70.791% |
| PureTech Health plc | -167.19 Million USD | 66.588% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 647.955% |
| Seer, Inc. | -4.24 Million USD | -1217.547% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -895.746% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 496.733% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 56093.345% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -83.401% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 66.794% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 134.539% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -0.45% |
| ChromaDex Corporation | -24.04 Million USD | -132.302% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -635.44% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -135.942% |
| CRISPR Therapeutics AG | -150.84 Million USD | 62.966% |
| Precision BioSciences, Inc. | -85.41 Million USD | 34.593% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 190.591% |
| Innoviva, Inc. | 255.56 Million USD | 121.859% |
| Summit Therapeutics Inc. | 34.67 Million USD | 261.112% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -132.408% |
| ESSA Pharma Inc. | -33.62 Million USD | -66.155% |
| GlycoMimetics, Inc. | -40.98 Million USD | -36.305% |
| GT Biopharma, Inc. | -1.02 Million USD | -5371.499% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 17.584% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 58.335% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -93.489% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -74055.096% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -81.012% |
| Aptose Biosciences Inc. | -8.19 Million USD | -581.696% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -1685.352% |
| Soligenix, Inc. | -4.95 Million USD | -1028.202% |
| Century Therapeutics, Inc. | 847 Thousand USD | 6695.514% |
| Kura Oncology, Inc. | -20.11 Million USD | -177.682% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -36.5% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -565.206% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 3166.595% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -1647.388% |
| Autolus Therapeutics plc | -186.59 Million USD | 70.062% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -13.305% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 79.744% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 263.021% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 133.987% |
| GRI Bio, Inc. | -1.79 Million USD | -3013.935% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -521.883% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -67.977% |
| IGM Biosciences, Inc. | -72.6 Million USD | 23.059% |
| INmune Bio, Inc. | -25.41 Million USD | -119.842% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 137.008% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -10.275% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -243.792% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -1836.41% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 246.953% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -35.642% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 275.205% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 114.781% |
| Verastem, Inc. | -37.27 Million USD | -49.858% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -515.717% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -7.717% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -269.105% |
| Histogen Inc. | -7.48 Million USD | -646.147% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -158.548% |
| Surrozen, Inc. | -32.66 Million USD | -71.026% |
| Organovo Holdings, Inc. | -1.5 Million USD | -3606.967% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1228.992% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 394.638% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 2235.474% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 1444.177% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -566.543% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -28.594% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -283.238% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 82.366% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -7636.753% |
| Apollomics, Inc. | -27.39 Million USD | -103.92% |
| Amarin Corporation plc | -191.04 Million USD | 70.758% |
| Mesoblast Limited | 55.96 Million USD | 199.823% |
| Turnstone Biologics Corp. | -14.58 Million USD | -283.05% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -120.876% |
| Synaptogenix, Inc. | -28.66 Million USD | -94.91% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -5868.376% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 214.635% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -6380.073% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -668.833% |
| Exelixis, Inc. | -73.05 Million USD | 23.526% |
| Better Therapeutics, Inc. | -860 Thousand USD | -6395.814% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -132.641% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 76.856% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 7689.537% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -651.048% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 4554.864% |
| Gritstone bio, Inc. | 39.49 Million USD | 241.464% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 33.575% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -2022.38% |
| Avid Bioservices, Inc. | 169.72 Million USD | 132.914% |
| Insmed Incorporated | 721.62 Million USD | 107.741% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -511.102% |
| MediWound Ltd. | -5.32 Million USD | -949.681% |
| OmniAb, Inc. | 9.2 Million USD | 707.019% |
| Alector, Inc. | -35.63 Million USD | -56.758% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 164.98% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -1033.604% |
| Zai Lab Limited | -775 Million USD | 92.792% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 116.404% |
| Aura Biosciences, Inc. | -21.52 Million USD | -159.531% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 32.27% |
| Immunic, Inc. | -45.34 Million USD | -23.211% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 71.087% |
| Veracyte, Inc. | -203.82 Million USD | 72.592% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 108.752% |
| FibroGen, Inc. | 56.76 Million USD | 198.409% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 727.333% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -1876.03% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -2598.29% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 101.217% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -1572.074% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 66.34% |
| TG Therapeutics, Inc. | 17.86 Million USD | 412.753% |
| Galecto, Inc. | -21.21 Million USD | -163.311% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -134.871% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 103.56% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -128.277% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -385.478% |
| XBiotech Inc. | -200.02 Million USD | 72.071% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 33.575% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 1333.746% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -58.421% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 27.654% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 1081.62% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 67.219% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 39.524% |
| Vaxxinity, Inc. | 10.13 Million USD | 651.362% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 107.587% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -418.818% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 15.301% |
| NexImmune, Inc. | -3.13 Million USD | -1682.717% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -1517.993% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -269.68% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -106.14% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -522.367% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -44743.668% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -37.691% |
| Ainos, Inc. | 4.07 Million USD | 1469.911% |
| Pluri Inc. | 22.82 Million USD | 344.706% |
| Prothena Corporation plc | -608.34 Million USD | 90.817% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 52.959% |
| Celularity Inc. | 65.19 Million USD | 185.694% |
| Rallybio Corporation | -24.1 Million USD | -131.782% |
| Cue Biopharma, Inc. | -33.81 Million USD | -65.185% |
| MeiraGTx Holdings plc | -40.3 Million USD | -38.613% |
| Omeros Corporation | 331.17 Million USD | 116.868% |
| Humacyte, Inc. | -22.48 Million USD | -148.439% |
| Immunocore Holdings plc | -358.59 Million USD | 84.421% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -127.32% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -80.784% |
| Blueprint Medicines Corporation | 702.83 Million USD | 107.948% |
| CalciMedica, Inc. | -5.53 Million USD | -910.199% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 70.32% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -446.936% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -39.531% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -67.997% |
| Pulmatrix, Inc. | -10.41 Million USD | -436.277% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -834.649% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -46.463% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 49.854% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 6.806% |
| Cytokinetics, Incorporated | 642.37 Million USD | 108.697% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -859.368% |
| Nutriband Inc. | -251.65 Thousand USD | -22098.469% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -63.733% |
| Vor Biopharma Inc. | 4.3 Million USD | 1399.163% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 99.074% |
| Evogene Ltd. | -19.63 Million USD | -184.527% |
| ProKidney Corp. | -56.23 Million USD | 0.661% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -14.776% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -504.773% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 104.096% |
| CorMedix Inc. | -43.05 Million USD | -29.758% |
| BioLineRx Ltd. | 7.33 Million USD | 861.505% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -103.401% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 221.057% |
| Atai Life Sciences N.V. | -28.55 Million USD | -95.616% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 2604.518% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -144.846% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 414.993% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 25.588% |
| MediciNova, Inc. | -50.78 Million USD | -10.004% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 29.111% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -248239.631% |
| GeoVax Labs, Inc. | -6.45 Million USD | -765.761% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 72.043% |
| Biomea Fusion, Inc. | -166.57 Million USD | 66.462% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 68.787% |
| Mereo BioPharma Group plc | -51.46 Million USD | -8.539% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 41.099% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 80.983% |
| Absci Corporation | -72.59 Million USD | 23.05% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1323.478% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 76.171% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 40.703% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 41.623% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -42.973% |
| Allakos Inc. | -24.97 Million USD | -123.68% |
| Imunon, Inc. | -4.21 Million USD | -1225.723% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -278.945% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 58.742% |
| BioAtla, Inc. | -109.01 Million USD | 48.754% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 7689.537% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -5849.308% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 566.856% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -163.472% |
| XOMA Corporation | -29 Million USD | -92.634% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -237.343% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -519.61% |
| aTyr Pharma, Inc. | -7.44 Million USD | -649.953% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 55.178% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 73.163% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 31.689% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 39.778% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -6401.983% |
| Akari Therapeutics, Plc | -3.84 Million USD | -1352.9% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 3542.254% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 104.046% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -4601.823% |
| UroGen Pharma Ltd. | 4.39 Million USD | 1372.239% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 149.228% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 77729.86% |
| Orgenesis Inc. | 21.78 Million USD | 356.445% |
| Entera Bio Ltd. | -10.62 Million USD | -425.581% |
| GH Research PLC | -78.07 Million USD | 28.45% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -150.646% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -109.55% |
| Xencor, Inc. | 29.64 Million USD | 288.45% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -2736.007% |
| Replimune Group, Inc. | 1.41 Million USD | 4056.374% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -22710.198% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 55.81% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -4601.823% |
| Portage Biotech Inc. | -4.98 Million USD | -1021.542% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -248239.631% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 15.514% |
| OncoCyte Corporation | -6.56 Million USD | -751.196% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 6325.005% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -1126.259% |
| Purple Biotech Ltd. | -14.13 Million USD | -295.134% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -135.157% |
| scPharmaceuticals Inc. | -6.54 Million USD | -753.537% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -234.672% |
| HilleVax, Inc. | -165.48 Million USD | 66.242% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -2101.103% |
| Tharimmune, Inc. | -10.93 Million USD | -410.857% |
| Genprex, Inc. | -6.73 Million USD | -729.134% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 84.853% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 36.848% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -3887.438% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -1584.2% |
| OKYO Pharma Limited | -826.84 Thousand USD | -6656.26% |
| Savara Inc. | 153 Thousand USD | 36612.418% |
| Curis, Inc. | -23.88 Million USD | -133.868% |
| Daré Bioscience, Inc. | -5.15 Million USD | -983.074% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -7098.858% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -799.871% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 4814.262% |
| BeiGene, Ltd. | -2.25 Billion USD | 97.521% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 552.762% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 90.815% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 69.899% |
| Erasca, Inc. | -37.21 Million USD | -50.107% |
| bluebird bio, Inc. | 108.57 Million USD | 151.454% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -4237.627% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 114.75% |
| DBV Technologies S.A. | -126.98 Million USD | 56.008% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -4237.627% |
| Moderna, Inc. | -2.9 Billion USD | 98.078% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -439.645% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -414.023% |
| Molecular Templates, Inc. | 707 Thousand USD | 8001.556% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -78.075% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 116.117% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 31.925% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 39.1% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -73.104% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -62.509% |
| MacroGenics, Inc. | -66.98 Million USD | 16.602% |
| RenovoRx, Inc. | -1.17 Million USD | -4662.489% |
| Adicet Bio, Inc. | -138.78 Million USD | 59.748% |
| Prime Medicine, Inc. | -27.94 Million USD | -99.936% |
| Aditxt, Inc. | 18.12 Million USD | 408.285% |
| Adagene Inc. | -87.62 Million USD | 36.248% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1241.135% |
| Quantum-Si incorporated | -118.55 Million USD | 52.88% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 255.156% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -647.426% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -15.162% |
| SciSparc Ltd. | -2.06 Million USD | -2605.278% |
| Vericel Corporation | 1.27 Million USD | 4474.628% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -365.856% |
| Minerva Neurosciences, Inc. | 41 Million USD | 236.24% |
| Generation Bio Co. | 31.44 Million USD | 277.639% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 68.144% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -80.655% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 147.914% |
| Invivyd, Inc. | -198.47 Million USD | 71.854% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 38.115% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -2229.911% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 21.085% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -718.52% |
| 2seventy bio, Inc. | 181.71 Million USD | 130.743% |
| ADMA Biologics, Inc. | 90.06 Million USD | 162.026% |
| Clene Inc. | 3.34 Million USD | 1772.575% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -515.059% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -159.7% |
| GeoVax Labs, Inc. | -6.45 Million USD | -765.761% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 83.766% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -114.864% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 131.443% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -1265.345% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 1216.833% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -972.452% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 57.128% |
| Evaxion Biotech A/S | 5.28 Million USD | 1156.661% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 50.373% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 57.444% |
| Trevena, Inc. | 2.25 Million USD | 2574.048% |
| Surrozen, Inc. | -32.66 Million USD | -71.026% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -8.453% |
| Cingulate Inc. | 3.08 Million USD | 1912.188% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -1802.077% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 877.292% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -501.255% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 29.574% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 57.502% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 47.069% |
| Clearmind Medicine Inc. | -3.94 Million USD | -1316.92% |
| Kronos Bio, Inc. | -36.05 Million USD | -54.945% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 693.729% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 3931.216% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -2.964% |
| Statera Biopharma, Inc. | 14.41 Million USD | 487.503% |
| ImmunityBio, Inc. | 618.22 Million USD | 109.036% |
| Korro Bio, Inc. | -132.94 Million USD | 57.979% |
| Kineta, Inc. | -4.54 Million USD | -1130.214% |
| BioVie Inc. | -17.73 Million USD | -215.04% |
| Codexis, Inc. | -43.27 Million USD | -29.103% |
| Celularity Inc. | 65.19 Million USD | 185.694% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -1662.827% |
| Celcuity Inc. | 6.78 Million USD | 923.527% |
| Virax Biolabs Group Limited | -3.36 Million USD | -1560.176% |
| Cibus, Inc. | -8.07 Million USD | -591.557% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -1220.974% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 1322.407% |
| IN8bio, Inc. | -16.38 Million USD | -240.863% |
| Kodiak Sciences Inc. | -103.87 Million USD | 46.22% |
| Annexon, Inc. | -193.75 Million USD | 71.168% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 155277.778% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -219.241% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -1490.208% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 105.299% |
| Eyenovia, Inc. | 1.25 Million USD | 4538.223% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 307.634% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1622.603% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -68.027% |
| Arcellx, Inc. | -296.95 Million USD | 81.188% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -186.394% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 5.114% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -169.523% |
| Moolec Science SA | 117.61 Thousand USD | 47596.939% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -45.483% |
| Geron Corporation | 14.76 Million USD | 478.457% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -47.328% |
| Royalty Pharma plc | 5.65 Billion USD | 100.987% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 60.498% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -699.265% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -941.683% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 60.304% |
| Humacyte, Inc. | -22.48 Million USD | -148.439% |
| Structure Therapeutics Inc. | -124.33 Million USD | 55.071% |
| 89bio, Inc. | -289.05 Million USD | 80.673% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -121.314% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -3033.146% |
| Genelux Corporation | -6.89 Million USD | -709.741% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -79.864% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 166.824% |
| Notable Labs, Ltd. | -9.77 Million USD | -471.44% |
| Liquidia Corporation | -80.17 Million USD | 30.323% |
| Mustang Bio, Inc. | -3.73 Million USD | -1395.289% |
| Immunovant, Inc. | -635.22 Million USD | 91.206% |
| Quantum-Si incorporated | -118.55 Million USD | 52.88% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -218.06% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -1248.395% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 795.951% |
| Acasti Pharma Inc. | -23 Million USD | -142.834% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -1559.05% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -243.792% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 59.442% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -1692.603% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -151.277% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -200.845% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 66.999% |
| PepGen Inc. | -60.67 Million USD | 7.922% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -143.141% |
| United Therapeutics Corporation | -507.7 Million USD | 88.997% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -192.084% |
| Solid Biosciences Inc. | -47.75 Million USD | -16.993% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -6380.073% |
| Immuneering Corporation | -54.94 Million USD | -1.677% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -1228.992% |
| Silo Pharma, Inc. | -3.52 Million USD | -1485.106% |
| Belite Bio, Inc | -87.27 Million USD | 35.988% |
| XOMA Corporation | -29 Million USD | -92.634% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 20.981% |
| Bionomics Limited | 227 Million USD | 124.609% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 51.958% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2105.448% |
| uniQure N.V. | -102.95 Million USD | 45.737% |
| Cassava Sciences, Inc. | -121.13 Million USD | 53.883% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -1241.135% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 236.417% |
| Forte Biosciences, Inc. | -11.96 Million USD | -367.051% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -1705.442% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 52801.887% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -1622.603% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 727.333% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -653.29% |
| Altimmune, Inc. | -134.48 Million USD | 58.461% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 128.205% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -2105.448% |
| Compugen Ltd. | -12.9 Million USD | -332.92% |
| Peak Bio, Inc. | 10.34 Million USD | 640.263% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -19639.929% |
| Benitec Biopharma Inc. | -50.58 Million USD | -10.442% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 46.459% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 384.368% |
| Zura Bio Limited | -99.8 Million USD | 44.027% |
| PolyPid Ltd. | 6.17 Million USD | 1005.413% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 175.37% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 384.368% |
| Instil Bio, Inc. | 75.35 Million USD | 174.131% |
| argenx SE | -2.02 Billion USD | 97.247% |
| Immunome, Inc. | -97.02 Million USD | 42.425% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -148.34% |
| Verona Pharma plc | -220.44 Million USD | 74.658% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 22.133% |
| Shattuck Labs, Inc. | -121.42 Million USD | 53.993% |
| CervoMed Inc. | -7.79 Million USD | -616.863% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 69.884% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -1177.475% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 57.595% |
| Moolec Science SA | 117.61 Thousand USD | 47596.939% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -2341.633% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 451.382% |
| AnaptysBio, Inc. | -18.15 Million USD | -207.774% |
| Design Therapeutics, Inc. | -18.15 Million USD | -207.791% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 20.626% |
| NeurAxis, Inc. | 145.7 Thousand USD | 38441.798% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 597.365% |
| Lumos Pharma, Inc. | -28.49 Million USD | -96.062% |
| Achilles Therapeutics plc | -126.92 Million USD | 55.986% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 22.133% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -8419.36% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -168.915% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 3931.216% |
| Nutriband Inc. | -251.65 Thousand USD | -22098.469% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -324.144% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -650.86% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 116.421% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 335.365% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 87.516% |
| Palisade Bio, Inc. | -12.06 Million USD | -363.102% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 60.186% |
| Beam Therapeutics Inc. | -262.72 Million USD | 78.736% |
| Neurogene Inc. | -131.95 Million USD | 57.664% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 356.069% |
| AEON Biopharma, Inc. | -4.88 Million USD | -1044.754% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 85.189% |
| Sesen Bio, Inc. | -112.55 Million USD | 50.366% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 44.058% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -2279.426% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -43.146% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 32.922% |
| Athira Pharma, Inc. | -88.99 Million USD | 37.231% |
| Vaccinex, Inc. | -1.28 Million USD | -4237.267% |
| HCW Biologics Inc. | 2.85 Million USD | 2055.56% |
| XOMA Corporation | -29 Million USD | -92.634% |
| Nektar Therapeutics | 210.24 Million USD | 126.572% |
| Arvinas, Inc. | -313.8 Million USD | 82.198% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 3542.254% |
| Merus N.V. | -192.88 Million USD | 71.038% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 193.13% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -705.189% |
| Rezolute, Inc. | -68.16 Million USD | 18.05% |
| Clene Inc. | 3.34 Million USD | 1772.575% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -323.629% |
| BeyondSpring Inc. | -13.75 Million USD | -306.136% |
| Synlogic, Inc. | -6.68 Million USD | -735.662% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 5026.279% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -560.721% |
| Peak Bio, Inc. | 10.34 Million USD | 640.263% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 32.22% |
| Krystal Biotech, Inc. | -350.23 Million USD | 84.05% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 145.006% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 66.944% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -1669.447% |
| MannKind Corporation | 143.89 Million USD | 138.822% |
| Ikena Oncology, Inc. | -109.15 Million USD | 48.822% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -637.868% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -68.773% |
| Gossamer Bio, Inc. | 180.35 Million USD | 130.974% |
| CohBar, Inc. | -5.93 Million USD | -841.941% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -87.791% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 1323.478% |
| Legend Biotech Corporation | -949.39 Million USD | 94.116% |
| Mural Oncology plc | -255.84 Million USD | 78.165% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 273.41% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -1085.911% |
| Disc Medicine, Inc. | -358.28 Million USD | 84.408% |
| Champions Oncology, Inc. | 4.81 Million USD | 1260.931% |
| REGENXBIO Inc. | 54.76 Million USD | 202.001% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -20674.468% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 63.01% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -519.884% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 30.761% |
| Vaxart, Inc. | -8.24 Million USD | -577.879% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -11.327% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 56.07% |
| Cellectis S.A. | -43.85 Million USD | -27.383% |
| Longeveron Inc. | -2.9 Million USD | -1821.045% |
| Repare Therapeutics Inc. | -107.85 Million USD | 48.206% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 105.769% |
| Inozyme Pharma, Inc. | 12 Million USD | 565.378% |
| Revolution Medicines, Inc. | -608.2 Million USD | 90.815% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -4441.789% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 78.929% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 62.775% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -257.027% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -7449.189% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 99.416% |
| Denali Therapeutics Inc. | -74.86 Million USD | 25.38% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -365.856% |
| Veru Inc. | 4.77 Million USD | 1268.711% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -396.746% |
| Cingulate Inc. | 3.08 Million USD | 1912.188% |
| Passage Bio, Inc. | 4.58 Million USD | 1318.408% |
| Context Therapeutics Inc. | -14.44 Million USD | -286.607% |
| Exicure, Inc. | 5.84 Million USD | 1055.103% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 75.751% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -41.178% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 456.026% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 5.027% |
| Nuvalent, Inc. | -335.38 Million USD | 83.343% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 3321.051% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 24.997% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -528.391% |
| OmniAb, Inc. | 9.2 Million USD | 707.019% |
| Anew Medical, Inc. | 1.43 Million USD | 3999.851% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 441.014% |
| Lipocine Inc. | -4.75 Million USD | -1074.948% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 49.135% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 466.778% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -10.275% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 324.426% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -731.186% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 15.135% |
| Ocugen, Inc. | -32.52 Million USD | -71.778% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 34.719% |
| Q32 Bio Inc. | -37.94 Million USD | -47.212% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -8795.541% |
| Alumis Inc. Common Stock | -13.52 Million USD | -312.92% |
| Equillium, Inc. | -22.39 Million USD | -149.482% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -118.492% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -71.221% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -22433.53% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 141.676% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 1846.842% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 17108.839% |
| Dominari Holdings Inc. | 195 Thousand USD | 28748.205% |
| Edesa Biotech, Inc. | -5.26 Million USD | -960.66% |
| vTv Therapeutics Inc. | -8.91 Million USD | -526.489% |
| Bio-Techne Corporation | 267.74 Million USD | 120.864% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -244.648% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 52.695% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -564.81% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -341.578% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 77.209% |
| Nkarta, Inc. | 57.29 Million USD | 197.496% |
| BioCardia, Inc. | 212 Thousand USD | 26450.943% |
| Iterum Therapeutics plc | 13.43 Million USD | 515.717% |